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Summary 
While bronchiolitis is considered a relatively homogenous viral infection, these results provide 
novel evidence to support the emerging hypothesis that RSV and RV bronchiolitis may have 
different mechanisms that involve a complex interplay between virus, microbiome, and host. 
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 2 
ABSTRACT 
Background: Bronchiolitis, the leading cause of US infant hospitalizations, is most commonly 
caused by respiratory syncytial virus (RSV) followed by rhinovirus (RV). Conventional 
perception is that bronchiolitis is a single entity, albeit with different viral etiologies and degrees 
of severity.  
Methods: We conducted a cross-sectional study of nasopharyngeal aspirates from 106 infants 
hospitalized with either RSV-only (n=80) or RV-only (n=26) bronchiolitis. We performed 
metabolomics analysis and 16S rRNA gene sequencing on all samples, and metagenomic 
sequencing on 58 of the 106 samples.  
Results: Infants with RSV-only and RV-only infections had significantly different 
nasopharyngeal metabolome profiles (P<0.001) and bacterial metagenome profiles (P<0.05). 
RSV-only was associated with metabolites from a range of pathways and a microbiome 
dominated by Streptococcus pneumoniae. By contrast, RV-only was associated with increased 
essential and non-essential N-acetyl amino acids and high relative abundance of Haemophilus 
influenzae.  These co-occurring species were associated with driving the bacterially-derived 
metabolic pathways. Multi-omic analysis showed that both the virus and the microbiome were 
significantly associated with the metabolic function in infants hospitalized with bronchiolitis.  
Conclusion: Although study replication is necessary, these results highlight that bronchiolitis is 
not a uniform disease between RSV and RV infections, a result with future implications for 
prevention and treatment. 
 
Key words: Bronchiolitis, respiratory syncytial virus, rhinovirus, metabolomics, microbiome.  
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 3 
INTRODUCTION 
 Bronchiolitis, a lower respiratory infection in infants, is an important public health 
problem worldwide and the leading cause of US infant hospitalizations [1]. Respiratory syncytial 
virus (RSV) and rhinovirus (RV) account for ~85% of the viruses causing severe bronchiolitis 
[2]. Although different viruses cause bronchiolitis, the American Academy of Pediatrics (AAP) 
recommends that clinicians not test children with bronchiolitis for viruses, since treatment does 
not vary by viral etiology [3]. Furthermore, due to the lack of clinical trials demonstrating 
consistently beneficial responses to pharmacotherapy, the 2014 AAP clinical practice guideline 
discusses bronchiolitis as a single, relatively homogenous entity [4,5].  
 Recently, however, we identified distinct clinical phenotypes of bronchiolitis, signaling 
that bronchiolitis probably is a heterogeneous condition [6]. Furthermore, compared to children 
with RSV bronchiolitis, children with RV bronchiolitis have a shorter hospital length-of-stay [2], 
are significantly more likely to be treated with systemic corticosteroids [7],  and have an 
increased risk of childhood asthma [7,8]. Although indicative of heterogeneity, these 
associations between viral etiology and outcomes do not provide insight into the underlying 
pathobiology of bronchiolitis, which involves complex interplay between the virus, microbiome, 
and host. Thus, we hypothesized that RSV and RV infections would be associated with 
underlying metabolic differences - as manifested by differences in the airway microbiome and 
metabolome. To test this hypothesis, we applied metabolomic and metagenomic approaches to 
the nasopharyngeal aspirates (NPA) from infants hospitalized with bronchiolitis. This integrated 
multi-omic approach examined molecular differences between RSV and RV pathobiology while 
accounting for both microbial and host factors.  
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METHODS 
Study design, setting, and participants 
 The study design, setting, participants, and methods of data collection are from the 35th 
Multicenter Airway Research Collaboration (MARC-35) [9]. Briefly, using a standardized 
protocol, site investigators at 17 sites across 14 U.S. states enrolled infants hospitalized with an 
attending physician diagnosis of bronchiolitis. Bronchiolitis was defined by the AAP guidelines – 
acute respiratory illness with some combination of rhinitis, cough, tachypnea, wheezing, 
crackles, and retractions [3]. In order to make the timing of sample collection more 
synchronous, we excluded infants with previous enrollment, those who were transferred to a 
participating hospital >24 hours after the original hospitalization and those who were consented 
>24 hours after hospitalization. We also excluded those with known heart-lung disease, 
immunodeficiency, immunosuppression, or gestational age <32 weeks. All patients were treated 
at the discretion of the treating physician. The institutional review board at each of the 
participating hospitals approved the study. Written informed consent was obtained from the 
parent or legal guardian. 
 We selected MARC-35 samples for metabolomic analysis to examine severity of illness 
[10] as well as RSV-only vs RV-only infections. Given the cost of this testing and the volume of 
sample required, we not only limited the overall sample size for testing, but also selected 
nasopharyngeal samples with sufficient volume for the metabolome and metagenomic WGS 
testing.  For the present analysis we analyzed the 106 samples with RSV-only or RV-only 
infections. Of the 106 samples, all had 16S rRNA gene sequencing data and 58 had metagenomic 
whole genome shotgun (WGS) sequencing data. Detailed descriptions of the sample preparation, 
data acquisition and processing, and statistical analysis may be found in the Online Supplement 
(Supplementary Methods). 
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 5 
Sample collection and testing 
Sample collection: NPA samples were collected by trained site investigators and stored at 
−80 °C using a standardized protocol [2]. All samples were handled and processed identically.  
Virology testing: Viral genomic load was determined as previously described [11]. A Ct 
value <40 was considered positive. CT-values provide a semi-quantitative measure of viral load, 
with an inverse linear relationship between viral load and CT-values. Thus, the inverse of the CT-
values (i.e., viral load) was applied for analysis. 
Metabolomic profiling: Metabolomics was performed by Metabolon (Durham, NC) using 
ultra performance liquid chromatography tandem-mass spectrometry (UPLC-MS/MS) in both 
positive and negative ionization mode. All samples were blinded to Metabolon and processed in 
a random order. Sample preparation was carried out as described previously [12].  
Bacterial 16S rRNA gene profiling: Bacterial genomic DNA was extracted from the 
nasopharyngeal samples using MOBIO PowerSoil DNA Isolation Kit (Mo Bio Laboratories; 
Carlsbad, CA) as described previously [13]. The sequencing methods were adapted from those 
developed for the NIH-Human Microbiome Project [14] using the V4 region (515F and 806R 
[15]) and sequenced on the MiSeq platform (Illumina; SanDiego, CA) using the 2 x 250 bp 
paired-end protocol. Resulting reads were quality filtered using strict merging criteria and biom 
tables were rarified to 1,500 reads per sample.  
Metagenomic whole genome shotgun sequencing: Metagenomic WGS sequencing was 
available for 58 nasopharyngeal samples[10]. Individual libraries constructed from each sample 
were sequenced using the 2x100 bp paired-end read protocol on the HiSeq platform (Illumina). 
The process of quality filtering, trimming and demultiplexing was performed using a pipeline 
developed at the Baylor College of Medicine.  
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 6 
Statistical analyses 
The primary exposure was RSV-only or RV-only infection and the primary outcome was 
the nasopharyngeal airway metabolome. Orthogonal partial least squares-discriminatory 
analysis (OPLS-DA) was performed using MetaboAnalyst 3.0 and validated using 2000 random 
permutations [16]. Significant metabolites were determined using two-tailed Welch’s t-test and 
adjusted for multiple comparisons with the false discovery rate (FDR) algorithm [17]. Linear 
regression models adjusted for 7 potential confounding variables (age, sex, preterm, antibiotics, 
systemic corticosteroids pre-hospitalization, positive pressure ventilation (PPV), and hospital 
site) and were FDR corrected. MixOmics [18] was implemented in R version 3.3 [19] based on 
sparse partial least squares regression (sPLS) and was performed in canonical mode with LASSO 
penalization. FishTaco (functional shifts taxonomic contributors) was used to determine which 
species was associated with “reducing” or “driving” the significantly altered functions [20] and 
model-based integration of metabolite observations and species abundances (MIMOSA) was 
applied to determine biologically feasible correlations between the WGS bacterial KEGG 
orthologs (KOs) and the resulting metabolites of likely bacterial origin [21].  
 
RESULTS 
Study population 
 Nasopharyngeal metabolomic and microbiome data were generated from 106 infants 
enrolled into the MARC-35 study, a 17-center cohort study of 1,016 infants hospitalized with 
bronchiolitis [9]. Compared with the non-analytic MARC-35 cohort (n=910), patients in the 
current analytic (n=106) cohort were younger and more likely to require PPV, defined as 
continuous positive pressure ventilation and/or endotracheal intubation (Supplementary 
Table 1). The 106 infants in the analytic cohort had a median age at hospitalization of 3 months 
(interquartile range; IQR, 1–5 months) and 61% were male. Eighty (75%) were infected with 
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 7 
RSV-only and 26 (25%) were infected with RV-only (i.e., no other co-infecting virus was 
detected among 16 viruses tested). Patient characteristics did not differ significantly between 
the two virus groups, with the exception of higher proportion of non-Hispanic white and greater 
use of PPV in the RSV-only group (Table 1).  
 
Infants with RSV-only or RV-only have significantly different metabolomic profiles 
 Metabolomic analysis detected a total of 254 metabolites.. When comparing infants with 
RSV-only bronchiolitis to those with RV-only bronchiolitis, the metabolomic profiles clustered 
distinctly based on the viral etiology (Figure 1A). This difference was validated using 2000 
permutations (P<0.001). Since the use of PPV was significantly greater in infants with RSV-only 
and may influence the metabolites (Table 1), we removed the infants who underwent PPV from 
the analysis and still found significant differences in the metabolomic profiles between RSV-only 
and RV-only infants (P < 0.001). Metabolites associated with RSV-only were from a range of 
super-pathways, including carbohydrate metabolism (N-acetylglucosamine-N-
acetylgalactosamine), lipid metabolism (mevalonolactone), amino acid metabolism (5-
oxoproline), and energy metabolism (2-methylcitrate-homocitrate) (Figure 1B). By contrast, 
metabolites associated with RV-only infection consisted primarily of N-acetyl metabolites from 
the amino acid super-pathway, specifically, N-acetylthreonine, N-acetylleucine, N-
acetylisokeucine, N-acetylphenyalanine, N-acetylvaline, N-acetylglutamate, N-acetyltyrosine, 
and N-acetyllysine (Figure 1B).  
 Of the 254 detected metabolites, there were 31 metabolites that significantly differed between 
RSV-only and RV-only infections by relative intensity, with 25 metabolites significant even after 
adjustment for seven covariates, including race/ethnicity and PPV (FDR P<0.05; Table 2). These 
associations between the qualitative viral differences (i.e., viral presence or absence) and all 254 
detected metabolites were also supported by correlations between quantitative viral differences 
(i.e., genomic load of RSV and RV based on inverse CT values) and all detected metabolites 
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 8 
(Figure 1C). In other words, not only were the metabolites different based on the infecting 
virus, but also the amount of virus correlated with increased metabolite intensity. Of the 
samples with detectable virus, the median viral load Ct values for RSV was 23.0 (IQR 21.5 – 26.4) 
and for RV was 26.4 (IQR 24.6– 28.1). 
 
Infants with RSV-only or RV-only infection have significantly different bacterial functional 
potential primarily associated with S. pneumoniae and H. influenzae, respectively 
Since RSV and RV infect an airway colonized with bacteria, we conducted metagenomic 
WGS sequencing to determine the functional potential of the microbiome (i.e., the presence, but 
not necessarily expression, of genes in microbial genomes). From the 106 nasopharyngeal 
samples, 58 were included in the metagenomic analyses (39 infants from RSV-only and 19 
infants from RV-only). There were no demographic differences between the RSV-only and RV-
only groups in the metagenomic subset, although infants with RSV-only infection were more 
likely to undergo PPV (Supplementary Table 2). Infants with either RSV-only or RV-only 
infection had significantly different metagenomic (metabolomic potential) profiles (permutation 
P=0.043) (Figure 2). 
We performed further analysis of the metagenomic data using FishTaco which 
determines taxa that are associated with “reducing” or “driving” functional shifts [20]. This 
analysis showed that nine bacterially-derived metabolic pathways were significantly different 
between infants with RSV-only and RV-only infection (Figure 2B). Among infants with RSV-only, 
S. pneumoniae relative abundance was associated with driving the functional shift in all nine 
pathways. By contrast, Moraxella catarrhalis was associated with driving four of the nine 
pathways and reducing the remaining five pathways. Among infants with RV-only infection, H. 
influenzae was associated with driving all nine pathways and Prevotella melaninogenica was 
associated with reducing all nine pathways. The more granular module-level analysis was 
comparable to the broader pathway-level analysis, except energy metabolism modules were 
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 9 
reduced by S. pneumoniae and M. catarrhalis in RSV-only bronchiolitis, and by H. influenzae in 
RV-only bronchiolitis (Supplementary Figure 1). Furthermore, in infants with RSV-only, S. 
pneumoniae was associated with driving carbohydrate and lipid metabolite modules while 
Streptococcus mitis was associated with reducing these modules, demonstrating that species 
within the same genus may influence modules differently. 
 
Multi-omic analysis showed the virus and dominant bacteria were both associated with 
the metabolomic profiles  
 The three dominant bacterial OTUs (operational taxonomic unit) from the 16S rRNA 
gene profiling (representing 80% of the total bacterial community) were characterized by 
metagenomic data as S. pneumoniae, H. influenzae, and M. catarrhalis species. Examining viral-
bacterial associations in the current analytic cohort, we found that RSV-only infection was 
associated with a high relative abundance of S. pneumoniae and RV-only infection was associated 
with high relative abundance of H. influenzae (Supplementary Figure 2). However, given the 
dominance of all three bacteria (i.e., S. pneumoniae, H. influenzae, and M. catarrhalis) and 
previously published viral-microbial associations from the entire MARC-35 cohort [9], we 
included all three dominant species in the analysis.  
Among the 254 metabolites, the relative abundance of S. pneumoniae was positively 
correlated with metabolites from sphingolipid metabolism (Supplementary Figure 3). 
However, sphingolipid metabolites were not associated with RSV-only infections. Consistent 
with these results, the network analysis showed that the relative abundance of S. pneumoniae 
had only weak positive correlations with metabolites significantly increased in RSV-only 
infection (Figure 3). By contrast, H. influenzae was positively correlated with the N-acetyl 
metabolites from amino acid metabolism that are increased in RV-only infections, and was 
negatively correlated with all other metabolites (Figure 3 and Supplementary Figure 3). The 
abundance of M. catarrhalis was positively correlated with metabolites from a range of 
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 10 
pathways, but none of the metabolites associated with either RSV-only or RV-only infections 
(Figure 3 and Supplementary Figure 3). 
Permutational multivariate analysis of variance using distance matrices (adonis) was 
utilized to test if either the virus or bacterial species had a greater association with the 
metabolomic profiles [22]. As the adonis function is based on sequential sum of squared 
deviations from a centroid, the order of the factors (i.e., if the virus was entered first or second 
in the model) was tested using both permutations. The virus (RSV-only or RV-only) was 
statistically significant when entered as the first factor (P = 0.04), but not when entered as the 
second factor (P = 0.14). Similarly, the bacterial species (dominance by S. pneumoniae, H. 
influenzae, M. catarrhalis, or a mixed community) was statistically significant when entered 
as the first factor (P = 0.049), but not when entered as the second factor (P = 0.10). These 
results suggest that both the viral etiology and the bacterial species are associated with the 
metabolomic profiles and that both are relevant in infants hospitalized with bronchiolitis.  
 
Significant metabolites were host-derived based on computational analysis 
 We employed MIMOSA to ascertain which metabolites were either bacterially-derived or 
host-derived, based on metagenome orthology. Although there were significant metagenomic 
(metabolomic potential) differences between infants with RSV-only and those with RV-only 
infection, MIMOSA analysis of the 254 metabolites estimated that 19 metabolites (7%) were 
derived from bacteria (Supplementary Table 3). None of the 31 metabolites that significantly 
differed between infants with RSV-only and RV-only infection were bacterially-derived (Table 
2). Taken together, these results suggest that most metabolites that distinguish RSV-only from 
RV-only infections are host-derived.  
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DISCUSSION 
In this novel multi-omic analysis of nasopharyngeal airway samples collected from 
infants hospitalized with bronchiolitis, RSV-only and RV-only infections were associated with 
significantly different metabolic function. RSV-only bronchiolitis had significantly increased 
metabolites from a range of pathways, whereas infants with RV-only bronchiolitis had increased 
N-acetyl amino acids. Moreover, higher viral genomic load positively correlated with higher 
intensity of the metabolites associated with RSV and RV infection. RSV and RV co-occurred with 
bacterial species (e.g., RSV with S. pneumoniae and RV with H. influenzae), and the associated 
metagenomes significantly differed between RSV-only and RV-only infections. Thus, these data 
demonstrate, for the first time, that RSV and RV are associated with different metabolic 
pathways and that the associated bacterial functional capacity is derived primarily from S. 
pneumoniae in RSV bronchiolitis and H. influenzae in RV bronchiolitis.  
Although the clinical phenotype of bronchiolitis due to different viruses is considered 
indistinguishable by some experts [23], comparing epidemiologic data of children with RV to 
those with RSV bronchiolitis demonstrates that children with RV have different demographics 
[2,24], medical histories [25], hospital treatment [25], short-term outcomes [6], and long-term 
outcomes [7,25]. The present results provide the first multi-omic comparison demonstrating 
pathobiological differences between RSV and RV bronchiolitis. Higher genomic load of RSV and 
RV was positively correlated with a higher intensity of the metabolites that distinguished RSV 
from RV. Although this finding is intriguing given the association between higher RSV genomic 
load and increased severity of illness [26], the same genomic load-severity association has not 
been found in RV [27]. While the relevance of genomic viral load requires additional validation, 
given the epidemiological and now pathobiological differences between RSV and RV, future 
clinical trials for infants with bronchiolitis should consider stratifying infants based on viral 
etiology.  
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RV-only infected infants hospitalized with bronchiolitis had altered amino acid 
metabolism, particularly related to N-acetyl metabolism. H. influenzae, which co-occurred with 
RV, was also associated with these metabolites. Nα-acetylation is the process of irreversibly 
transferring an acetyl group from acetyl co-enzyme A to the α-amino group of an amino acid 
[28]. It is among the most abundant co- and post- translational protein modifications in 
eukaryotes, but is less common in bacteria [29]. The functional implication of acetylation in RV 
bronchiolitis remains unclear. Notably, in asthma, there is an increase in histone 
acetyltransferase activity that is treatable with corticosteroids [30]. Although speculative, the 
association between early childhood RV wheezing illnesses and increased risk of school age 
asthma [31–33] may be explained in part by the altered host amino acid metabolism in RV 
bronchiolitis seen in the present results. 
The bacterial derivation (vs host) of 7% of detected metabolites was comparable to a 
previous report in adult sputum showing 4% of detected metabolites were microbial [34]. The 
KEGG orthologs from H. influenzae were associated with the generation of essential amino acids, 
but neither S. pneumoniae nor other microbes correlated with the generation of amino acids. 
Indeed, S. pneumoniae cannot synthesize amino acids [35], producing peptidases, proteases, and 
utilizing cell wall transporters to uptake amino acids [36]. Therefore, in addition to dietary 
intake, H. influenzae provides access to essential amino acids, which may have contributed to the 
observed increase in RV-associated N-acetyl metabolites. S. pneumoniae and H. influenzae were 
responsible for the same bacterial metabolic pathway functions in RSV and RV, respectively. 
Additionally, we found cases of S. pneumoniae driving and S. mitis reducing the same modules, 
suggesting important effects of different species within the same genera [20]. Taken together, 
these results suggest that both the virus and bacteria have important influences on the 
metabolomic profiles, as supported by the adonis results. Thus, future bronchiolitis studies may 
need to account for both viral and bacterial communities and clinicians may need to begin 
thinking of “viral” bronchiolitis as being due to a complex interplay among the infecting virus, 
microbiome, and host response. 
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The current results offer novel findings and additional evidence of microbial (virus and 
bacteria) and host interaction in the pathobiology of bronchiolitis as investigated within the 
MARC-35 cohort. We have previously found that infants with RV bronchiolitis have shorter 
hospital length-of-stay [37,38] and associations with Haemophilus and Moraxella microbial 
dominance when compared with RSV, which is associated with microbial dominance by 
Streptococcus [9]. And although Haemophilus and Streptococcus are associated with increased 
severity of illness [13,39] and Moraxella with less severe bronchiolitis [13], the results from the 
MARC studies underscore the complex bacterial, viral, and host interaction in bronchiolitis 
pathobiology [40,41]. 
 The current study has several potential limitations. First, bronchiolitis is mostly a 
disease of the lower airways and while nasopharyngeal samples may not provide a reliable 
representation of the lung microbiome [42] they are more easily obtained than lower airway 
samples [43]. Additionally, nasopharyngeal samples have further technical and ethical 
justification [43]. Second, the cross-sectional study design prevented temporal monitoring of 
viral and bacterial abundance and function, thus subsequent studies would benefit from 
longitudinal sampling, including, ideally, the collection of samples prior to hospitalization and 
samples from non-infectious control infants. Third, antibiotic data was limited to use prior to 
enrollment, but neither the exact antibiotic used nor the duration of administration was 
analyzed. However, there were no significant differences in antibiotic use prior to enrollment 
between infants with RSV-only and those with RV-only infections as shown in Table 1 (P = 
0.75). Fourth, significant financial expense of the techniques employed limited the number of 
samples that could be analyzed. Thus, the present results require validation not only in the full 
MARC-35 cohort, but also in an independent cohort. Indeed, such temporal and validation 
analyses would be necessary for biomarker identification. Finally, from an analytic standpoint, 
not all significant metabolites are present in the KEGG metabolic network model, meaning 
MIMOSA would be unable to analyze them. Thus, it is possible that some metabolites considered 
host-derived are products of novel microbial metabolism. Notwithstanding these limitations, the 
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current study provides novel evidence to support the emerging hypothesis that RSV and RV 
induce bronchiolitis through distinct metabolic pathways.  
Currently, most clinicians and researchers regard bronchiolitis as a relatively 
homogenous clinical entity.  Although replication is needed, these data demonstrate the 
underlying heterogeneity of bronchiolitis by showing that RSV and RV are associated with 
different metabolic pathways, and that both the virus and the co-occurring bacterial species play 
a role in the host metabolism.  Bronchiolitis is also currently considered a viral condition, but 
these data provide further evidence that bronchiolitis involves a complex interplay among virus, 
microbiome, and host. Indeed, these results not only challenge long-standing ideas about 
bronchiolitis, but also, given the lack of effective pharmacotherapies for this very common 
condition [3–5], have important implications for the future development of novel treatments. 
 
 
 
 
  
Downloaded from https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jix680/4774594
by University of Newcastle user
on 05 January 2018
Ac
ce
pte
d M
an
us
cri
pt
 
 15 
FOOTNOTE 
 
FUNDING 
This work was supported by the grants UG3 OD-023253, U01 AI-087881, R01 AI-114552, R01 
AI-108588, and R21 HL-129909 from the National Institutes of Health (Bethesda, MD). The 
content of this manuscript is solely the responsibility of the authors and does not necessarily 
represent the official views of the National Institutes of Health.   
 
ACKNOWLEDGMENTS  
We thank the patients of MARC-35 for study participation. We are grateful to Tulin Ayvaz from 
the CMMR for her work in sample processing; and Ginger Metcalf, Donna Muzny, and Richard 
Gibbs from the BCM Human Genome Sequencing Center for their support in sequencing. We also 
thank Dr. Alkis Togias at NIH (Bethesda, MD) for helpful comments about the study results. 
 
CONFLICT OF INTERESTS 
Dr. Mansbach has provided bronchiolitis-related consultation for Regeneron. Drs. Ajami and 
Petrosino own shares at Diversigen Inc., a microbiome research company. Dr. Piedra provided 
bronchiolitis-related consultation for Gilead, Novavax, and Regeneron. The other authors have 
no financial relationships relevant to this article to disclose.  
 
 
 
Downloaded from https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jix680/4774594
by University of Newcastle user
on 05 January 2018
Ac
ce
pte
d M
an
us
cri
pt
 
 16 
 
 
REFERENCES 
1.  Hasegawa K, Mansbach JM, Camargo CA. Infectious pathogens and bronchiolitis 
outcomes. Expert Rev Anti Infect Ther. 2014; 12(7):817–828.  
2.  Mansbach JM, Piedra PA, Teach SJ, et al. Prospective multicenter study of viral etiology 
and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc 
Med. 2012; 166(8):700–6.  
3.  Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical Practice Guideline: The Diagnosis, 
Management, and Prevention of Bronchiolitis. Pediatrics. 2014; 134(5):e1474–e1502.  
4.  Corneli HM, Zorc JJ, Mahajan P, et al. A Multicenter, Randomized, Controlled Trial of 
Dexamethasone for Bronchiolitis. N Engl J Med. 2007; 357(4):331–339.  
5.  Plint AC, Johnson DW, Patel H, et al. Epinephrine and Dexamethasone in Children with 
Bronchiolitis. N Engl J Med. 2009; 360(20):2079–2089.  
6.  Dumas O, Mansbach JM, Jartti T, et al. A clustering approach to identify severe 
bronchiolitis profiles in children. Thorax. 2016; 71(8):712–718.  
7.  Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life 
predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008; 
178(7):667–672.  
8.  Rubner FJ, Jackson DJ, Evans MD, et al. Early life rhinovirus wheezing, allergic 
sensitization, and asthma risk at adolescence. J Allergy Clin Immunol. 2017; 139(2):501–
507.  
9.  Mansbach JM, Hasegawa K, Henke DM, et al. Respiratory syncytial virus and rhinovirus 
Downloaded from https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jix680/4774594
by University of Newcastle user
on 05 January 2018
Ac
ce
pte
d M
an
us
cri
pt
 
 17 
severe bronchiolitis are associated with distinct nasopharyngeal microbiota. J Allergy Clin 
Immunol. 2016; 137(6):1909–1913e4.  
10.  Stewart CJ, Mansbach JM, Wong MC, et al. Associations of Nasopharyngeal Metabolome 
and Microbiome with Severity Among Infants with Bronchiolitis: A Multi-omic Analysis. 
Am J Respir Crit Care Med. 2017; 196(7):882–891.  
11.  Hasegawa K, Jartti T, Mansbach JM, et al. Respiratory syncytial virus genomic load and 
disease severity among children hospitalized with bronchiolitis: multicenter cohort 
studies in the United States and Finland. J Infect Dis. 2015; 211(10):1550–9.  
12.  Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, Nontargeted 
Ultrahigh Performance Liquid Chromatography/Electrospray Ionization Tandem Mass 
Spectrometry Platform for the Identification and Relative Quantification of the Small-
Molecule Complement of Biological Systems. Anal Chem. 2009; 81(16):6656–6667.  
13.  Hasegawa K, Mansbach JM, Ajami NJ, et al. Association of nasopharyngeal microbiota 
profiles with bronchiolitis severity in infants hospitalised for bronchiolitis. Eur Respir J. 
2016; 48(5):1329–1339.  
14.  Human T, Project M, Huttenhower C, et al. A framework for human microbiome research. 
Nature. 2012; 486(7402):207–214.  
15.  Caporaso JG, Lauber CL, Walters WA, et al. Ultra-high-throughput microbial community 
analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012; 6(8):1621–4.  
16.  Xia J, Sinelnikov I V, Han B, Wishart DS. MetaboAnalyst 3.0--making metabolomics more 
meaningful. Nucleic Acids Res. 2015; 43(W1):W251-7.  
17.  Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful 
Approach to Multiple Testing. J R Stat Soc Ser B. 1995; 57(1):289–300.  
18.  Lê Cao K-A, González I, Déjean S. integrOmics: an R package to unravel relationships 
Downloaded from https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jix680/4774594
by University of Newcastle user
on 05 January 2018
Ac
ce
pte
d M
an
us
cri
pt
 
 18 
between two omics datasets. Bioinformatics. 2009; 25(21):2855–6.  
19.  Team RC. R: A language and environment for statistical computing [Internet]. Vienna, 
Austria: R Foundation for Statistical Computing; 2014. Available from: http://www.r-
project.org/ 
20.  Manor O, Borenstein E. Systematic Characterization and Analysis of the Taxonomic 
Drivers of Functional Shifts in the Human Microbiome. Cell Host Microbe. 2017; 
21(2):254–267.  
21.  Noecker C, Eng A, Srinivasan S, et al. Metabolic Model-Based Integration of Microbiome 
Taxonomic and Metabolomic Profiles Elucidates Mechanistic Links between Ecological 
and Metabolic Variation. mSystems. 2016; 1(1):e00013-15.  
22.  Anderson MJ. A new method for non-parametric multivariate analysis of variance. Austral 
Ecol. 2001; 26(1):32–46.  
23.  Meissner HC. Viral Bronchiolitis in Children. Ingelfinger JR, editor. N Engl J Med. 2016; 
374(1):62–72.  
24.  Hasegawa K, Linnemann RW, Avadhanula V, et al. Detection of respiratory syncytial virus 
and rhinovirus in healthy infants. BMC Res Notes. 2015; 8:718.  
25.  Mansbach JM, Clark S, Teach SJ, et al. Children Hospitalized with Rhinovirus Bronchiolitis 
Have Asthma-Like Characteristics. J Pediatr. 2016; 172:202–204.e1.  
26.  DeVincenzo JP, Wilkinson T, Vaishnaw A, et al. Viral load drives disease in humans 
experimentally infected with respiratory syncytial virus. Am J Respir Crit Care Med. 
2010; 182(10):1305–1314.  
27.  Jartti T, Hasegawa K, Mansbach JM, Piedra PA, Camargo CA. Rhinovirus-induced 
bronchiolitis: Lack of association between virus genomic load and short-term outcomes. J 
Allergy Clin Immunol. 2015; 136(2):509–12.e11.  
Downloaded from https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jix680/4774594
by University of Newcastle user
on 05 January 2018
Ac
ce
pte
d M
an
us
cri
pt
 
 19 
28.  Drazic A, Myklebust LM, Ree R, Arnesen T. The world of protein acetylation. Biochim 
Biophys Acta - Proteins Proteomics. 2016; 1864(10):1372–1401.  
29.  Linda I. H, Bruno P. L, Alan J. W. Bacterial protein acetylation: The dawning of a new age. 
Mol Microbiol. 2010; 77(1):15–21.  
30.  Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: Importance in 
inflammatory lung diseases. Eur Respir J. 2005; 25(3):552–563.  
31.  Mansbach JM, Camargo CA, Jr. Respiratory viruses in bronchiolitis and their link to 
recurrent wheezing and asthma. Clin Lab Med. 2009; 29(4):741–55.  
32.  Papadopoulos NG, Papi A, Psarras S, Johnston SL. Mechanisms of rhinovirus-induced 
asthma. Paediatr Respir Rev. 2004; 5(3):255–260.  
33.  Stone CA, Miller EK. Understanding the Association of Human Rhinovirus with Asthma. 
Clin Vaccine Immunol. 2015; 23(1):6–10.  
34.  Quinn RA, Phelan V V, Whiteson KL, et al. Microbial, host and xenobiotic diversity in the 
cystic fibrosis sputum metabolome. ISME J. 2016; 10(6):1483–1498.  
35.  Härtel T, Eylert E, Schulz C, et al. Characterization of central carbon metabolism of 
Streptococcus pneumoniae by isotopologue profiling. J Biol Chem. 2012; 287(6):4260–
74.  
36.  Ericsson AC, Personett AR, Grobman ME, Rindt H, Reinero CR. Composition and predicted 
metabolic capacity of upper and lower airway microbiota of healthy dogs in relation to 
the fecal microbiota. Wilson BA, editor. PLoS One. 2016; 11(5):e0154646. 
37.  Mansbach JM, Piedra PA, Teach SJ, et al. Prospective multicenter study of viral etiology 
and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc 
Med. 2012; 166(8):700–6.  
Downloaded from https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jix680/4774594
by University of Newcastle user
on 05 January 2018
Ac
ce
pte
d M
an
us
cri
pt
 
 20 
38.  Jartti T, Aakula M, Mansbach JM, et al. Hospital Length-of-stay Is Associated With 
Rhinovirus Etiology of Bronchiolitis. Pediatr Infect Dis J. 2014; 33(8):829–834.  
39.  Stewart CJ, Mansbach JM, Wong MC, et al. Associations of nasopharyngeal metabolome 
and microbiome with severity among infants with bronchiolitis: A multiomic analysis. Am 
J Respir Crit Care Med. 2017; 196(7):882–891.  
40.  Mansbach JM, Hasegawa K, Ajami NJ, et al. Serum LL-37 levels associated with severity of 
bronchiolitis and viral etiology. Clin Infect Dis. 2017; 65(6):967–975.  
41.  Hasegawa K, Mansbach JM, Ajami NJ, et al. The relationship between nasopharyngeal 
CCL5 and microbiota on disease severity among infants with bronchiolitis. Allergy Eur J 
Allergy Clin Immunol. 2017; 72(11):1796–1800.  
42.  Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations 
in the healthy human respiratory tract. Am J Respir Crit Care Med. 2011; 184(8):957–
963.  
43.  Poole A, Urbanek C, Eng C, et al. Dissecting childhood asthma with nasal transcriptomics 
distinguishes subphenotypes of disease. J Allergy Clin Immunol. 2014; 133(3):670–
678.e12.  
  
Downloaded from https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jix680/4774594
by University of Newcastle user
on 05 January 2018
Ac
ce
pte
d M
an
us
cri
pt
 
 21 
TABLES 
Table 1 – Characteristics of infants hospitalized with either respiratory syncytial virus-
only (RSV-only) or rhinovirus-only (RV-only) bronchiolitis, n=106 
Characteristics 
RSV-only 
(n=80) 
RV-only  
(n=26) 
P Value 
Age in months, median (IQR) 2.7 (1-5)  2.7 (1.4-7.9) 0.64 
Male sex 47 (59%) 18 (69%) 0.34 
Race/ethnicity 
  
<0.001 
   Non-Hispanic white 43 (54%) 11 (42%) 
 
   Non-Hispanic black 11 (14%) 6 (23%) 
 
   Hispanic 21 (26%) 8 (31%) 
 
   Other 5 (6%) 1 (4%) 
 
Maternal smoking during pregnancy 5 (6%) 4 (15%) 0.18 
Prematurity (32-37 weeks) 16 (20%) 7 (27%) 0.46 
C-section delivery  29 (36%) 10 (38%) 0.87 
Postnatal smoke exposure at home 9 (12%) 0 (0%) 0.97 
Number of siblings, median (IQR) 1 (1-2) 1 (1-2) 0.54 
History of antibiotic use prior to enrolment 22 (28%) 8 (31%) 0.75 
History of corticosteroid use prior to enrolment 11 (14%) 3 (12%) 0.77 
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Positive pressure ventilation 16 (23%)  0 (0%) 0.03 
Abbreviations: RSV, respiratory syncytial virus; RV, rhinovirus; IQR, interquartile range. 
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 Table 2 – Metabolites associated with respiratory syncytial virus-only (RSV-only) and 
rhinovirus-only (RV-only) infections among infants hospitalized for bronchiolitis  
Increased 
in 
Metabolite Sub-Pathway Super-Pathway 
KEGG 
Compoun
d 
P 
Value 
Adjuste
d P 
Value* 
RSV 
N-acetylglucosamine-N-
acetylgalactosamine 
Aminosugar Metabolism Carbohydrate   <0.001 0.002 
Mevalonolactone Mevalonate Metabolism Lipid 
 
<0.001 00.02 
Cystine 
Methionine, Cysteine, SAM and Taurine 
Metabolism 
Amino Acid C00491 0.033 0.004 
Palmitic-amide Fatty Acid, Amide Lipid 
 
0.001 0.004 
2-methylcitrate-
homocitrate 
TCA Cycle Energy 
 
0.001 0.016 
Caprate (10:0) Medium Chain Fatty Acid Lipid C01571 0.018 0.024 
Diglycerol Chemical Xenobiotics 
 
0.025 0.044 
Beta-hydroxyisovalerate 
Leucine, Isoleucine and Valine 
Metabolism 
Amino Acid 
 
0.015 0.054 
Pregnen-diol-disulfate Steroid Lipid 
 
0.018 0.060 
Laurate (12:0) Medium Chain Fatty Acid Lipid C02679 0.046 0.081 
RV 
N-acetylthreonine 
Glycine, Serine and Threonine 
Metabolism 
Amino Acid   <0.001 0.002 
N-acetyltyrosine Phenylalanine and Tyrosine Metabolism Amino Acid 
 
<0.001 0.002 
N6-acetyllysine Lysine Metabolism Amino Acid C02727 0.001 0.002 
Adenine Purine Metabolism, Adenine containing Nucleotide C00147 0.000 0.002 
Azelate (nonanedioate) Fatty Acid, Dicarboxylate Lipid C08261 0.000 0.002 
N-acetylleucine 
Leucine, Isoleucine and Valine 
Metabolism 
Amino Acid C02710 0.001 0.002 
Glucuronate Aminosugar Metabolism Carbohydrate C00191 0.005 0.002 
N-acetylvaline 
Leucine, Isoleucine and Valine 
Metabolism 
Amino Acid 
 
0.001 0.002 
N-acetylphenylalanine Phenylalanine and Tyrosine Metabolism Amino Acid C03519 0.001 0.002 
N-acetylisoleucine 
Leucine, Isoleucine and Valine 
Metabolism 
Amino Acid 
 
0.003 0.014 
1-stearoyl-2-linoleoyl-GPE 
(18:0/18:2) 
Phospholipid Metabolism Lipid 
 
0.040 0.014 
N-acetyltaurine 
Methionine, Cysteine, SAM and Taurine 
Metabolism 
Amino Acid 
 
0.017 0.017 
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* Linear regression models adjusting for age, race/ethnicity, history of prematurity, history of 
antibiotic use prior to the enrollment, use of systemic corticosteroids during the pre-
hospitalization visit, use of PPV, and hospital site. 
Abbreviations: RSV, respiratory syncytial virus; RV, rhinovirus; KEGG, Kyoto encyclopedia of 
genes and genomes 
FIGURE LEGENDS 
 
Figure 1. Nasopharyngeal airway metabolomic profiles in infants with respiratory 
syncytial virus-only (RSV-only) or rhinovirus-only (RV-only) bronchiolitis. Analysis 
includes all infants (n = 106) and 254 detected metabolites. A) Orthogonal partial least squares 
discriminant analysis (OPLS-DA) score scatter plot of samples classified according to RSV-only 
(red) or RV-only (green) infection. Each dot represents the metabolomic profile of one infant. 
Ellipses show 95% confidence interval. Metabolomic profiles were significantly different 
between RSV and RV (permutation P <0.001). B) OPLS-DA S-plot of metabolites, where each dot 
represents a metabolite. Metabolites in red are discriminatory in RSV-only infection and 
metabolites in green are discriminatory in RV-only infection. C) Heatmap showing the 
Sulfate Chemical Xenobiotics C00059 0.011 0.024 
Glycerol Glycerolipid Metabolism Lipid C00116 0.017 0.024 
N-acetylglutamate Glutamate Metabolism Amino Acid C00624 0.005 0.031 
4-hydroxyphenylpyruvate Phenylalanine and Tyrosine Metabolism Amino Acid C01179 0.011 0.031 
Glycerol 3-phosphate Glycerolipid Metabolism Lipid C00093 0.017 0.031 
N-formylphenylalanine Phenylalanine and Tyrosine Metabolism Amino Acid 
 
0.011 0.031 
Gluconate Food Component/Plant Xenobiotics C00257 0.045 0.038 
N-acetylarginine 
Urea cycle; Arginine and Proline 
Metabolism 
Amino Acid C02562 0.014 0.060 
Folate Folate Metabolism 
Cofactors and 
Vitamins 
C00504 0.034 0.131 
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correlations of the viral genomic load (inverse CT value) of RSV and RV infections with the 
metabolomic profiles. Only the top 25 (of all 254 metabolites) most strongly correlated 
metabolites are shown. Canonical correlations are based on sparse partial least squares (sPLS). 
Colored squares on the left column denote metabolites significantly increased in RSV-only 
infection (red), significantly increased in RV-only infection (green), and not significant (gray), as 
per Table 2.  
 
Figure 2. Metabolic potential of the bacterial community among infants with respiratory 
syncytial virus-only (RSV-only) or rhinovirus-only (RV-only) infection. Analysis includes 
metagenomic infant subset (n = 58) and all KEGG orthologs (KOs; n = 3,883). A) Orthogonal 
partial least squares discriminant analysis (OPLS-DA) grouped by RSV-only (red) or RV-only 
(green) infection. Each dot represents the metagenomic profile of one infant. Metagenomic 
profiles were significantly different between RSV and RV (Permutation P = 0.043). B) FishTaco 
analysis determined the contribution of bacterial species to metabolic pathways (determined 
from KOs) that were significantly different between RSV-only and RV-only infections. Plots are 
divided by the nine significant pathways. In each plot, the bars with negative enrichment (left of 
the line) show the association between bacterial species reducing function and bars with 
positive enrichment (right of the line) show the association between bacterial species driving 
function. For each pathway, RV-only samples are on the top row and RSV-only samples are the 
bottom row.  
 
Figure 3. Association of infants hospitalized with respiratory syncytial virus-only (RSV-
only) and rhinovirus-only (RV-only) bronchiolitis with the nasopharyngeal microbiota. 
Analysis includes all infants (n = 106). Network plot showing all correlations greater than 0.5 
between the relative abundance of the three dominant bacterial genera (yellow) and the 31 
significant metabolites in RSV (red) or RV infection (green). Nodes are colored red or green 
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according to the significantly increased metabolite in RSV or RV infection. The metabolite names 
are colored according to the super-pathway. Edges are colored by canonical sparse partial least 
squares (sPLS) correlations. Relative abundance for the three dominant genera is based on 16S 
rRNA gene sequencing. OTUs were identified to species level based on metagenomic data.  
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